Exploring the innovation behind acquired companies
Acquisitions
May 26, 2026
•
9 min read
Re-entering the vaccine market with multiple sclerosis (MS) upside
May 20, 2026
8 min read
A founder-led startup aiming to solve gene therapy's "last mile" problem
May 6, 2026
11 min read
A long-acting diabetic eye disease play
May 4, 2026
Scooping a reverse merger for a TCE pipeline
Apr 29, 2026
13 min read
An oral HAE play
Apr 27, 2026
19 min read
A differentiated JAK play
Apr 21, 2026
Digging into the in vivo CAR-T gold rush
Apr 15, 2026
A bet on dual-payload ADCs
Apr 7, 2026
The advent of 3rd generation ADCs
Apr 6, 2026
10 min read
The story of the first FDA approved drug for Prader-Willi Syndrome (PWS) in patients four years of age and older
Apr 5, 2026
Rise of selective OX2 agonists for narcolepsy
